Gallant is advancing investigational stem cell therapies to help give pets more good years, making regenerative care more accessible.
Gallant has raised $18.0M in total funding. The most recent round was Series B. The last funding was announced in March 2025.
Gallant's investors include Alumni Ventures, Slow Ventures, Bling Capital, Maveron, Digitalis Ventures.
Gallant is headquartered in San Diego, United States.
Gallant is advancing investigational stem cell therapies to help give pets more good years, making regenerative care more accessible.
Gallant is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Gallant — Funding & Investors." VCBacked, March 15, 2025, https://www.vcbacked.co/company/gallant. Accessed July 19, 2026.
VCBacked. (2025). Gallant — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/gallant
{{cite web |title=Gallant — Funding & Investors |url=https://www.vcbacked.co/company/gallant |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated